Advisory for:NHS & ICB Commissioners

Independent clinical safety review and procurement advisory for commissioning organisations evaluating digital health products.

The Challenge

Where commissioning gets complex

NHS and ICB commissioners face growing pressure to evaluate an increasing volume of digital health submissions against clinical safety, data protection, and technical standards — often without dedicated in-house clinical safety expertise. The consequences of commissioning a product with inadequate safety documentation are significant. The consequences of rejecting a good product on procedural grounds are equally costly.

No in-house clinical safety officer for procurement review
Inconsistent evidence standards across supplier submissions
Pressure to commission at pace without compromising safety
DTAC and DCB0129 review expertise gaps within the team
Supplier submissions that are incomplete or poorly evidenced

Our Deliverables

What we help with

Efficiency
Submission Review

Independent clinical safety review of supplier documentation.

Operations
Procurement Advisory

Expert advisory across the full procurement evaluation process.

Future Readiness
Governance

Ongoing clinical governance support for commissioned products.

See what's possible

COMMISSIONER
REVIEW
Supplier Safety Case Review
INPUTS
Stack of supplier DCB0129 submissions for evaluation
ACTION
Review
Score
Gap Report
Recommendation
RESULT
ICB
DTAC
DTAC Compliance Benchmarking
INPUTS
Multiple supplier DTAC submissions under evaluation
ACTION
Assess
Compare
Evidence Quality Report
RESULT
NHS
GOVERNANCE
Post-Commissioning Safety Audit
INPUTS
Live commissioned product requiring annual review
ACTION
Review
Gap Identify
Remediation Plan
Report
RESULT

Typical outcomes

The impact of independent clinical assurance

Clear milestones, constant communication, and zero hand-waving. Here’s how we get from idea to impact.

~70%

reduction

in procurement

risk when supplier submissions are independently reviewed before award

~100%

of commissioned

products

reviewed with a qualified clinician — not a compliance checklist

“Commissioners are under pressure to move quickly and safely at the same time. Independent clinical assurance is what makes both possible.”

Dr Jide Idowu, Founder, SDHA

Independent review of six supplier DCB0129 submissions for an ICB evaluating remote monitoring tools. Clear assurance report produced for the procurement panel within three weeks.

DTAC evidence quality review for an NHS trust evaluating a patient-facing digital health platform. Gaps identified in two submissions before award, preventing a non-compliant commissioning decision.

Post-commissioning clinical safety audit for a mental health digital tool commissioned by an ICB. Annual review report produced and presented to the clinical governance committee.

Connect with an Expert

Let's map your compliance pathway

Tell us about your product and where you are in the process. We will identify your obligations and recommend the right next step.